论文部分内容阅读
目的:探讨肺性脑病患者C型利钠肽治疗前后的水平变化特点。方法:应用放射免疫法,检测35例肺性脑病患者在急性发作期和缓解期与正常对照组C型利钠肽的水平,并进行比较。结果:治疗后C型利钠肽水平显著高于对照组。结论:C型利钠肽可作为肺性脑病患者防治研究的良好指标。
Objective: To investigate the changes of C-type natriuretic peptide in patients with pulmonary encephalopathy before and after treatment. Methods: Radioimmunoassay was used to detect the levels of C-type natriuretic peptide in 35 cases of patients with pulmonary encephalopathy in acute attack and remission stage and normal control group. Results: After treatment, the C-type natriuretic peptide level was significantly higher than that of the control group. Conclusion: C-type natriuretic peptide can be used as a good indicator of prevention and treatment of patients with pulmonary encephalopathy.